Genomenon is a company headquartered in the United States.
Genomenon applies AI to genomic and scientific literature data to connect patient DNA variants to the supporting research, aiding clinical diagnosis and the development of disease treatments.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.